Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

Smolen, Josef S, Kalden, Joachim R, Scott, David L, Rozman, Blaz, Kvien, Tore K, Larsen, Arvi, Loew-Friedrich, Iris, Oed, Christine, Rosenburg, Ronald·1999·The Lancet

DOI 10.1016/s0140-6736(98)09403-3

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)09403-3

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases
Herrmann, M. L., Schleyerbach, R., & Kirschbaum, B. J. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00191-0 · Cited by 273
Clinical Pharmacokinetics of Leflunomide
Rozman, B. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241060-00003 · Cited by 250
Self-citation
The Definition and Measurement of Disease Modification in Inflammatory Rheumatic Diseases
Aletaha, D., & Smolen, J. S. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2005.09.005 · Cited by 152
Self-citation
Leflunomide: A Review of its Use in Active Rheumatoid Arthritis
Prakash, A., & Jarvis, B. (1999) · Drugs · doi:10.2165/00003495-199958060-00010 · Cited by 135
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
Jobanputra, P., Barton, P., Bryan, S., & Burls, A. (2002) · Health Technology Assessment · doi:10.3310/hta6210 · Cited by 126

Authors: Smolen, J. S., Kalden, J. R., Scott, D. L., Rozman, B., Kvien, T. K., Larsen, A., Loew-Friedrich, I., Oed, C., & Rosenburg, R.
Venue: The Lancet
Publisher: Elsevier BV
Published: 1999-01
Volume: 353
Issue: 9149
Pages: 259-266
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(98)09403-3
OpenAlex: W2111540856
Cited by: 771
References: 0
FWCI: 40.25
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review